Elashoff, Robert M.
University of California, Los Angeles,
United States
2025 Rank: 159661
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Statistics & Probability
Rank in SubField 1: 4866 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 159661 | 169952 |
| Total Cites | 1319 | 1483 |
| H-index | 15 | 16 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 17 | 17 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 419 | 475 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 994 | 1045 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.42 |
| Self-Citation Percentage |
11.06%
|
|
Elashoff, Robert M.
University of California, Los Angeles,
United States
2022 Rank: 107067
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Statistics & Probability
Rank in SubField 1: 4019 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 107067 | 112898 |
| Total Cites | 1566 | 1770 |
| H-index | 16 | 16 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 23 | 27 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 493 | 572 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1154 | 1236 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.43 |
| Self-Citation Percentage |
11.53%
|
|
Elashoff, Robert M.
University of California, Los Angeles,
United States
2021 Rank: 116635
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Statistics & Probability
Rank in SubField 1: 4153 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 116635 | 119755 |
| Total Cites | 2402 | 2684 |
| H-index | 19 | 22 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 27 | 28 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 706 | 814 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1775 | 1890 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.42 |
| Self-Citation Percentage |
10.51%
|
|
Elashoff, Robert M.
David Geffen School of Medicine at UCLA,
United States
2020 Rank: 118232
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Arthritis & Rheumatology
Rank in SubField 1: 4128 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 118232 | 119245 |
| Total Cites | 1823 | 2068 |
| H-index | 15 | 18 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 20 | 21 |
| Number of Single+First+Last Authored Papers | 79 | 79 |
| Total Cites to Single+First+Last Authored Papers | 478 | 575 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1323 | 1405 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.47 |
| Self-Citation Percentage |
11.85%
|
|